Myeloid leukemia in Prader-Willi syndrome

H. Dele Davies, Geraline L. Leusink, Athena McConnell, Marc Deyell, Suzanne B. Cassidy, Gordon H. Fick, Max J. Coppes

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Objective: To evaluate the frequency of cancers recorded by the Surveillance, Epidemiology, and End Results (SEER) Program in persons with Prader-Willi syndrome (PWS). Methods: A survey was mailed in 1994 to 1852 registrants of the PWS Association (USA) inquiring about a diagnosis of any type of benign tumor or cancer (malignant tumor or leukemia). The risk of developing cancer was then estimated by comparing the observed number of cancers in the PWS population during 1975 to 1994 to the expected number in the general US population using data from the 1971-1994 SEER Cancer Statistics Review. Results: Of the 1852 persons, 1160 (63%) responded, or 75% (1160/1552) of those who received the survey. The total number of observed cancer cases in the PWS study population was 8 versus 4.80 expected in the general US population (P = .1610). Three cases of myeloid leukemia were observed versus 0.075 leukemias expected (P = .0001). Conclusions: There appears to be an increased risk of myeloid leukemias, but not other cancers, among persons with PWS.

Original languageEnglish (US)
Pages (from-to)174-178
Number of pages5
JournalJournal of Pediatrics
Volume142
Issue number2
DOIs
StatePublished - Feb 1 2003

Fingerprint

Prader-Willi Syndrome
Myeloid Leukemia
Neoplasms
Population
Leukemia
SEER Program
Epidemiology

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Davies, H. D., Leusink, G. L., McConnell, A., Deyell, M., Cassidy, S. B., Fick, G. H., & Coppes, M. J. (2003). Myeloid leukemia in Prader-Willi syndrome. Journal of Pediatrics, 142(2), 174-178. https://doi.org/10.1067/mpd.2003.81

Myeloid leukemia in Prader-Willi syndrome. / Davies, H. Dele; Leusink, Geraline L.; McConnell, Athena; Deyell, Marc; Cassidy, Suzanne B.; Fick, Gordon H.; Coppes, Max J.

In: Journal of Pediatrics, Vol. 142, No. 2, 01.02.2003, p. 174-178.

Research output: Contribution to journalArticle

Davies, HD, Leusink, GL, McConnell, A, Deyell, M, Cassidy, SB, Fick, GH & Coppes, MJ 2003, 'Myeloid leukemia in Prader-Willi syndrome', Journal of Pediatrics, vol. 142, no. 2, pp. 174-178. https://doi.org/10.1067/mpd.2003.81
Davies HD, Leusink GL, McConnell A, Deyell M, Cassidy SB, Fick GH et al. Myeloid leukemia in Prader-Willi syndrome. Journal of Pediatrics. 2003 Feb 1;142(2):174-178. https://doi.org/10.1067/mpd.2003.81
Davies, H. Dele ; Leusink, Geraline L. ; McConnell, Athena ; Deyell, Marc ; Cassidy, Suzanne B. ; Fick, Gordon H. ; Coppes, Max J. / Myeloid leukemia in Prader-Willi syndrome. In: Journal of Pediatrics. 2003 ; Vol. 142, No. 2. pp. 174-178.
@article{60550944a0af426494a4e6e171384a98,
title = "Myeloid leukemia in Prader-Willi syndrome",
abstract = "Objective: To evaluate the frequency of cancers recorded by the Surveillance, Epidemiology, and End Results (SEER) Program in persons with Prader-Willi syndrome (PWS). Methods: A survey was mailed in 1994 to 1852 registrants of the PWS Association (USA) inquiring about a diagnosis of any type of benign tumor or cancer (malignant tumor or leukemia). The risk of developing cancer was then estimated by comparing the observed number of cancers in the PWS population during 1975 to 1994 to the expected number in the general US population using data from the 1971-1994 SEER Cancer Statistics Review. Results: Of the 1852 persons, 1160 (63{\%}) responded, or 75{\%} (1160/1552) of those who received the survey. The total number of observed cancer cases in the PWS study population was 8 versus 4.80 expected in the general US population (P = .1610). Three cases of myeloid leukemia were observed versus 0.075 leukemias expected (P = .0001). Conclusions: There appears to be an increased risk of myeloid leukemias, but not other cancers, among persons with PWS.",
author = "Davies, {H. Dele} and Leusink, {Geraline L.} and Athena McConnell and Marc Deyell and Cassidy, {Suzanne B.} and Fick, {Gordon H.} and Coppes, {Max J.}",
year = "2003",
month = "2",
day = "1",
doi = "10.1067/mpd.2003.81",
language = "English (US)",
volume = "142",
pages = "174--178",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Myeloid leukemia in Prader-Willi syndrome

AU - Davies, H. Dele

AU - Leusink, Geraline L.

AU - McConnell, Athena

AU - Deyell, Marc

AU - Cassidy, Suzanne B.

AU - Fick, Gordon H.

AU - Coppes, Max J.

PY - 2003/2/1

Y1 - 2003/2/1

N2 - Objective: To evaluate the frequency of cancers recorded by the Surveillance, Epidemiology, and End Results (SEER) Program in persons with Prader-Willi syndrome (PWS). Methods: A survey was mailed in 1994 to 1852 registrants of the PWS Association (USA) inquiring about a diagnosis of any type of benign tumor or cancer (malignant tumor or leukemia). The risk of developing cancer was then estimated by comparing the observed number of cancers in the PWS population during 1975 to 1994 to the expected number in the general US population using data from the 1971-1994 SEER Cancer Statistics Review. Results: Of the 1852 persons, 1160 (63%) responded, or 75% (1160/1552) of those who received the survey. The total number of observed cancer cases in the PWS study population was 8 versus 4.80 expected in the general US population (P = .1610). Three cases of myeloid leukemia were observed versus 0.075 leukemias expected (P = .0001). Conclusions: There appears to be an increased risk of myeloid leukemias, but not other cancers, among persons with PWS.

AB - Objective: To evaluate the frequency of cancers recorded by the Surveillance, Epidemiology, and End Results (SEER) Program in persons with Prader-Willi syndrome (PWS). Methods: A survey was mailed in 1994 to 1852 registrants of the PWS Association (USA) inquiring about a diagnosis of any type of benign tumor or cancer (malignant tumor or leukemia). The risk of developing cancer was then estimated by comparing the observed number of cancers in the PWS population during 1975 to 1994 to the expected number in the general US population using data from the 1971-1994 SEER Cancer Statistics Review. Results: Of the 1852 persons, 1160 (63%) responded, or 75% (1160/1552) of those who received the survey. The total number of observed cancer cases in the PWS study population was 8 versus 4.80 expected in the general US population (P = .1610). Three cases of myeloid leukemia were observed versus 0.075 leukemias expected (P = .0001). Conclusions: There appears to be an increased risk of myeloid leukemias, but not other cancers, among persons with PWS.

UR - http://www.scopus.com/inward/record.url?scp=0037329080&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037329080&partnerID=8YFLogxK

U2 - 10.1067/mpd.2003.81

DO - 10.1067/mpd.2003.81

M3 - Article

C2 - 12584540

AN - SCOPUS:0037329080

VL - 142

SP - 174

EP - 178

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 2

ER -